A child’s struggles bring home the promise of AI in healthcare

The power of AI in medicine has come to light in Alabama, where an 11-year-old in medical peril had the good fortune to have a dad who’s an AI-specialized computer programmer working in healthcare.

Stat News published a feature article on the case July 25.

While young Bertrand “Buddy” Might has been sick all his life and is still not out of the woods by any means, a recent hospitalization “showcased the increasing capacity of AI to spur scientific inquiry, and find answers, even in desperate circumstances,” Stat technology correspondent Casey Ross writes.  

Matt Might, PhD, Buddy’s father, runs the Precision Medicine Institute at the University of Alabama at Birmingham. Ross reports the university is now looking to incorporate Might’s team and their work into routine clinical care so they “can be called upon to assist physicians with challenging cases, a crucial step forward in the use of AI.”

Along with the great read, the piece presents videos and photos of the Might family that serve as reminders of what AI in healthcare is really all about.

Click to read and see:

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.